Sulfasalazine is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Chartwell Rx, Llc.. The primary component is Sulfasalazine.
| Product ID | 62135-960_46c24ff2-9761-4b7e-983c-05844642f862 |
| NDC | 62135-960 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Sulfasalazine |
| Generic Name | Sulfasalazine |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 1973-11-12 |
| Marketing Category | ANDA / |
| Application Number | ANDA080197 |
| Labeler Name | Chartwell RX, LLC. |
| Substance Name | SULFASALAZINE |
| Active Ingredient Strength | 500 mg/1 |
| Pharm Classes | Aminosalicylate [EPC],Aminosalicylic Acids [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2021-05-07 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0093-3234 | Sulfasalazine | Sulfasalazine |
| 0591-0796 | Sulfasalazine | Sulfasalazine |
| 0603-5801 | Sulfasalazine | sulfasalazine |
| 10544-288 | Sulfasalazine | sulfasalazine |
| 23155-019 | Sulfasalazine | Sulfasalazine |
| 33261-756 | Sulfasalazine | sulfasalazine |
| 43353-495 | Sulfasalazine | Sulfasalazine |
| 50090-0086 | Sulfasalazine | Sulfasalazine |
| 50090-2013 | Sulfasalazine | Sulfasalazine |
| 50268-730 | Sulfasalazine | Sulfasalazine |
| 59762-0104 | Sulfasalazine | Sulfasalazine |
| 68071-4215 | Sulfasalazine | Sulfasalazine |
| 68788-9021 | SULFASALAZINE | SULFASALAZINE |
| 70518-0185 | Sulfasalazine | Sulfasalazine |
| 70518-1829 | Sulfasalazine | Sulfasalazine |
| 59762-5000 | Sulfasalazine | Sulfasalazine |
| 63629-5688 | Sulfasalazine | Sulfasalazine |
| 70518-2342 | Sulfasalazine | Sulfasalazine |
| 0013-0101 | Azulfidine | Sulfasalazine |
| 0013-0102 | Azulfidine | Sulfasalazine |